SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Axsome Therapeutics schedules Q3 2026 earnings for Nov. 2

Axsome Therapeutics Inc. will release its third-quarter 2026 financial results before the market opens on Nov. 2, 2026. The company's management will host a conference call at 8:00 a.m. ET the same day.

AXSM.O